Leveraging Gene Expression Subgroups to Classify DLBCL Patients and Enrich for Clinical Benefit to a Novel Agent.
暂无分享,去创建一个
J. Cerhan | J. Parker | M. Trotter | C. Fontanillo | Amira Djebbari | P. Hagner | Yan Ren | M. Maurer | M. Pourdehnad | A. Risueño | G. Nowakowski | F. Towfic | S. Couto | Xin-Xin Wei | A. Gandhi | Maria Wang | Chung-Wein Lee | Clifton Drew | A. Djebbari | J. Parker | G. Nowakowski